Company Profiles

driven by the PitchBook Platform

Telsar Pharma

Description

Developer of a drug for a common inflammatory bowel disease. The company was formed through the partnership of Astellas Pharma and Drais Pharmaceuticals to develop and commercialize an Astellas drug compound which is a melanocortin receptor agonist for the potential treatment of ulcerative olitis.

2012

Founded

PRIVATE

Status

Series A

Latest Deal Type

$14M

Latest Deal Amount

$14M

Total Amount Raised

3

Investors

Description

Developer of a drug for a common inflammatory bowel disease. The company was formed through the partnership of Astellas Pharma and Drais Pharmaceuticals to develop and commercialize an Astellas drug compound which is a melanocortin receptor agonist for the potential treatment of ulcerative olitis.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

520 US Highway 22 Suite 201 Bridgewater, NJ 08807United States +1 (908) 895-1200
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Telsar Pharma's full profile, request a free trial.

    Telsar Pharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Telsar Pharma Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Telsar Pharma Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Astellas Venture ManagementCorporate Venture CapitalMinority000 0000000 0000
    InterWest PartnersVenture CapitalMinority000 0000000 0000
    Sutter Hill VenturesVenture CapitalMinority000 0000000 0000
    Astellas Venture Management Corporate Venture Capital
    InterWest Partners Venture Capital
    Sutter Hill Ventures Venture Capital

    Telsar Pharma Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Donna Tempel Ph.DPresident & Chief Executive Officer
    Donna Tempel Ph.D President & Chief Executive Officer

    Telsar Pharma Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Arnold Oronsky Ph.DInterWest PartnersManaging Director000 0000
    Jeffrey Bird Ph.DSutter Hill VenturesManaging Director000 0000
    Arnold Oronsky Ph.D Managing Director InterWest Partners
    Jeffrey Bird Ph.D Managing Director Sutter Hill Ventures
    Request full access to PitchBook